Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Verheij

Showing results (21-30 of 182) with videos related to

Pageof 19
Sort By:
Investigational New Drugs|July 14, 2005
Tumor and normal tissue pharmacokinetics of perifosine, an oral anti-cancer alkylphospholipidStefan R Vink, Jan H M Schellens, Wim J van Blitterswijk, et al.
Technical Innovations & Patient Support in Radiation Oncology|June 12, 2025
Exploratory health economic analyses to support decisions within the innovation process in radiotherapy: Magnetic Resonance Linear Accelerator as a case studyMarike J Ulehake, Ellen J L Brunenberg, Marcel Verheij, et al.
The Biochemical Journal|July 3, 2003
Different modes of internalization of apoptotic alkyl-lysophospholipid and cell-rescuing lysophosphatidylcholineArnold H Van Der Luit, Marianne Budde, Marcel Verheij, et al.
Journal of Surgical Oncology|April 11, 2012
Randomized trials and quality assurance in gastric cancer surgeryJohan L Dikken, Annemieke Cats, Marcel Verheij, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 3, 2015
The effect of age in breast conserving therapy: a retrospective analysis on pathology and clinical outcome dataWei Chen, Jan-Jakob Sonke, Joep Stroom, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2013
Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approachJohannes A Langendijk, Philippe Lambin, Dirk De Ruysscher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2005
Optimal locoregional treatment in gastric cancerEdwin P M Jansen, Henk Boot, Marcel Verheij, et al.
Anti-Cancer Drugs|February 6, 2003
Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt/PKB survival pathwayGerald A Ruiter, Shuraila F Zerp, Harry Bartelink, et al.
Radiation Research|July 27, 2016
Radiation-Induced Microvascular Injury as a Mechanism of Salivary Gland Hypofunction and Potential Target for RadioprotectorsAviram Mizrachi, Ana P Cotrim, Nora Katabi, et al.
International Journal of Cancer|October 29, 2002
Submicromolar doses of alkyl-lysophospholipids induce rapid internalization, but not activation, of epidermal growth factor receptor and concomitant MAPK/ERK activation in A431 cellsGerald A Ruiter, Marcel Verheij, Shuraila F Zerp, et al.
Pageof 19

Showing results (21-30 of 182) with videos related to

Sort By:
Pageof 19
Investigational New Drugs|July 14, 2005
Tumor and normal tissue pharmacokinetics of perifosine, an oral anti-cancer alkylphospholipidStefan R Vink, Jan H M Schellens, Wim J van Blitterswijk, et al.
Technical Innovations & Patient Support in Radiation Oncology|June 12, 2025
Exploratory health economic analyses to support decisions within the innovation process in radiotherapy: Magnetic Resonance Linear Accelerator as a case studyMarike J Ulehake, Ellen J L Brunenberg, Marcel Verheij, et al.
The Biochemical Journal|July 3, 2003
Different modes of internalization of apoptotic alkyl-lysophospholipid and cell-rescuing lysophosphatidylcholineArnold H Van Der Luit, Marianne Budde, Marcel Verheij, et al.
Journal of Surgical Oncology|April 11, 2012
Randomized trials and quality assurance in gastric cancer surgeryJohan L Dikken, Annemieke Cats, Marcel Verheij, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 3, 2015
The effect of age in breast conserving therapy: a retrospective analysis on pathology and clinical outcome dataWei Chen, Jan-Jakob Sonke, Joep Stroom, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2013
Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approachJohannes A Langendijk, Philippe Lambin, Dirk De Ruysscher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2005
Optimal locoregional treatment in gastric cancerEdwin P M Jansen, Henk Boot, Marcel Verheij, et al.
Anti-Cancer Drugs|February 6, 2003
Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt/PKB survival pathwayGerald A Ruiter, Shuraila F Zerp, Harry Bartelink, et al.
Radiation Research|July 27, 2016
Radiation-Induced Microvascular Injury as a Mechanism of Salivary Gland Hypofunction and Potential Target for RadioprotectorsAviram Mizrachi, Ana P Cotrim, Nora Katabi, et al.
International Journal of Cancer|October 29, 2002
Submicromolar doses of alkyl-lysophospholipids induce rapid internalization, but not activation, of epidermal growth factor receptor and concomitant MAPK/ERK activation in A431 cellsGerald A Ruiter, Marcel Verheij, Shuraila F Zerp, et al.
Pageof 19